Skip to main content

GPI 250 mg 907 Pill - white capsule/oblong, 19mm

Pill with imprint GPI 250 mg 907 is White, Capsule/Oblong and has been identified as Penicillamine 250 mg. It is supplied by Granules Pharmaceuticals Inc.

Penicillamine is used in the treatment of Rheumatoid Arthritis; Wilson's Disease; Cystinuria and belongs to the drug class antirheumatics. There is positive evidence of human fetal risk during pregnancy. Penicillamine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GPI 250 mg 907

Penicillamine 250 mg GPI 250 mg 907

Penicillamine

Imprint
GPI 250 mg 907
Strength
250 mg
Color
White
Size
19.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Antirheumatics
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Granules Pharmaceuticals Inc.
National Drug Code (NDC)
70010-0907

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.